Sorted By Test Name - Mayo Medical Laboratories

82037
FCYNS
57491
FFTHM
90354
presence of one or more of the high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 or 68).
Reference Values:
Satisfactory for evaluation. Negative for intraepithelial lesion.
Note: Abnormal results will be reviewed by a pathologist at an additional charge.
Clinical References: 1. Solomon D, Schiffman M, Tarone R: Comparison of three management
strategies for patients with atypical squamous cells of undetermined significance: baseline results from a
randomized trial. J Natl Cancer Inst 2001;93:293-299 2. Soloman D, Davey D, Kurman R, et al: The 2001
Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119 3.
Wright TC, Cox JT, Massad LS,et al: 2001 Consensus Guidelines for the management of women with
cervical cytological abnormalities. JAMA 2002;287:2120-2129
ThinPrep Screen, Without Physician Interpretation
Clinical Information: The ThinPrep PAP Test is an alternative preparation method for the cervical
pap screening test. The method utilizes a liquid-base technique that replaces the direct smear method of
the conventional PAP screen. This method is one of several new technologies developed to improve
visualization of cellular material by reducing smearing trauma, air drying artifact, and obscuring blood
and inflammation.In addition, variability in smearing technique is eliminated as the majority of processing
and preparation is performed in the laboratory under controlled conditions.
Useful For: Routine cytology screen for cervical abnormalities. The method is an alternative to
conventional PAP smears.
Interpretation: Standard reporting, as defined by the Bethesda System (TBS) is utilized.
Reference Values:
Satisfactory for evaluation. Negative for intraepithelial lesion.
Note: Abnormal results will be reviewed by a pathologist at an additional charge.
Clinical References: 1. Austin RM, Ramzey I: Increased detection of epithelial cell abnormalities by
liquid-based gynecologic cytology preparations. A review of accumulated data. Acta Cytol
1998;42:178-184 2. Guidos BJ, Selvaggi SM: Use of the ThinPrep PAP test in clinical practice. Diagn
Cytopathol 1999;20:70-73 3. Kurman RJ, Solomon D: The Bethesda system for reporting cervical/vaginal
cytologic diagnoses: definitions, criteria, and explanatory notes for terminology and specimen adequacy.
New York, NY, Springer-Verlag, 1994 4. Gay JD, Donaldson LD, Goellner JR: False-negative results in
cervical cytologic studies. Acta Cytol 1985;29:1043-1046
Thiocyanate, Serum
Reference Values:
Units: mg/dL
Toxic thiocyanate concentrations: Greater than 10 mg/dL
Test Performed by: Medtox Laboratories, Inc.
402 West County Road D
Saint Paul, MN 55112
Thiopental and Metabolite, Serum/Plasma
Reference Values:
Reporting limit determined each analysis
Thiopental
Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or MayoMedicalLaboratories.com Page 1731